Treatment Compliance in Children and Adolescents on ADHD Medication

Treatment Adherence and Compliance in Children and Adolescents on ADHD Medication and Emotional Expression in Clinical Practice

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00540826

Acronym

COMPLY

Enrollment

518

Registered

2007-10-08

Start date

2007-11-30

Completion date

2009-06-30

Last updated

2009-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ADHD

Brief summary

The primary research objective of this observational study is to evaluate treatment compliance over one year in children and adolescents who are newly initiated on medication approved for the treatment of ADHD in a routine clinical setting. Compliance will be assessed using the Pediatric Compliance Self-Rating (PCSR) Instrument. A patient will be considered as compliant at a given visit, if the PCSR score is at least 5, corresponding to taking the medication at least often.

Interventions

DRUGstimulants (any approved ADHD medication)

in-label use

DRUGAtomoxetine

in-label use

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to 17 Years

Healthy volunteers

Inclusion criteria

* 6-17 years old * diagnosis of ADHD according to ICD-10 or DSM-IV criteria * new initiation onto an approved medication to treat ADHD

Exclusion criteria

* no specific

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026